While employer-sponsored health benefits are not likely to disappear, changes that shift financial risk to employees are certain.
According to Deloitte, U.S. employers are concerned about continued rising healthcare costs; however, they are unaware of solutions that could improve the safety and quality of care, and simultaneously reduce cost. While employer-sponsored health benefits are not likely to disappear, changes that shift financial risk to employees are certain, according to the company’s survey.
The survey of employers with 50+ workers offering health benefits explores employers’ opinions about the U.S. healthcare system, the Patient Protection and Affordable Care Act (PPACA), and anticipated strategies for employee health benefits coverage and cost containment.
Survey results also revealed:
35% of employers surveyed grade system performance as an “A” or a “B.” Employers hold favorable views about the system’s clinical capabilities and medical innovation, but unfavorable views center on its wastefulness and high costs.
Employers believe that they have a “good” understanding of the PPACA. Familiarity with the individual mandate is the highest (72%). Most employers say their company is “not well prepared” to implement the 2014 provisions of the ACA.
30% think the PPACA is “a good start,” 59% “a step in the wrong direction.”
To manage healthcare costs, increased cost sharing with employees is considered the optimal strategy.
When considering healthcare related strategies to reduce the deficit, employers support reforms in medical liability, Medicare and Medicaid, and repeal/delay of the PPACA. Across-the-board cuts in government spending are considered a higher priority than changes to the healthcare system.
Go back to the Managed Healthcare Executive eNews newsletter.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More